Your browser doesn't support javascript.
loading
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer.
Sampath, Deepak; Zabka, Tanja S; Misner, Dinah L; O'Brien, Thomas; Dragovich, Peter S.
Afiliação
  • Sampath D; Department of Translational Oncology, Genentech Research and Early Development, South San Francisco, CA 94080, USA. Electronic address: dsampath@gene.com.
  • Zabka TS; Department of Safety Assessment, Genentech Research and Early Development, South San Francisco, CA 94080, USA.
  • Misner DL; Department of Safety Assessment, Genentech Research and Early Development, South San Francisco, CA 94080, USA.
  • O'Brien T; Department of Translational Oncology, Genentech Research and Early Development, South San Francisco, CA 94080, USA.
  • Dragovich PS; Department of Discovery Chemistry, Genentech Research and Early Development, South San Francisco, CA 94080, USA.
Pharmacol Ther ; 151: 16-31, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25709099
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nicotinamida Fosforribosiltransferase / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nicotinamida Fosforribosiltransferase / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article